Analysts Anticipate Apollo Medical Holdings Inc (NASDAQ:AMEH) Will Post Earnings of $0.13 Per Share

Wall Street analysts expect Apollo Medical Holdings Inc (NASDAQ:AMEH) to announce earnings per share of $0.13 for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Apollo Medical’s earnings. Apollo Medical posted earnings per share of $0.24 during the same quarter last year, which would indicate a negative year-over-year growth rate of 45.8%. The business is scheduled to report its next quarterly earnings report on Wednesday, November 13th.

On average, analysts expect that Apollo Medical will report full-year earnings of $0.33 per share for the current year. For the next financial year, analysts anticipate that the company will report earnings of $0.40 per share. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that that provide coverage for Apollo Medical.

Apollo Medical (NASDAQ:AMEH) last issued its earnings results on Friday, August 9th. The company reported $0.09 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.04. The business had revenue of $130.05 million during the quarter. Apollo Medical had a return on equity of 5.28% and a net margin of 1.94%.



A number of research analysts recently commented on the company. Zacks Investment Research lowered Apollo Medical from a “hold” rating to a “strong sell” rating in a research note on Friday, August 9th. ValuEngine lowered Apollo Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, August 20th. Finally, TheStreet upgraded Apollo Medical from a “d” rating to a “c-” rating in a research note on Friday, June 28th.

Shares of NASDAQ AMEH traded down $0.50 during trading hours on Friday, reaching $19.47. The stock had a trading volume of 97,523 shares, compared to its average volume of 158,214. The business’s fifty day moving average is $17.06 and its two-hundred day moving average is $17.72. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.14 and a quick ratio of 2.14. The company has a market cap of $716.92 million, a price-to-earnings ratio of 67.14, a PEG ratio of 12.10 and a beta of -0.95. Apollo Medical has a twelve month low of $13.36 and a twelve month high of $23.32.

In other Apollo Medical news, insider Kenneth T. Sim bought 6,000 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were bought at an average price of $16.01 per share, for a total transaction of $96,060.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Albert Waichow Young bought 5,000 shares of the firm’s stock in a transaction dated Wednesday, August 14th. The shares were acquired at an average price of $15.01 per share, for a total transaction of $75,050.00. Following the acquisition, the insider now directly owns 916,446 shares of the company’s stock, valued at approximately $13,755,854.46. The disclosure for this purchase can be found here. Insiders acquired 29,200 shares of company stock worth $467,784 over the last quarter. Company insiders own 11.83% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in shares of Apollo Medical by 9.6% during the 2nd quarter. Vanguard Group Inc. now owns 1,164,827 shares of the company’s stock worth $19,464,000 after buying an additional 102,267 shares during the period. Tower Research Capital LLC TRC boosted its position in shares of Apollo Medical by 1,518.0% during the second quarter. Tower Research Capital LLC TRC now owns 3,414 shares of the company’s stock worth $57,000 after purchasing an additional 3,203 shares in the last quarter. BlackRock Inc. boosted its position in shares of Apollo Medical by 98.7% during the second quarter. BlackRock Inc. now owns 728,124 shares of the company’s stock worth $12,167,000 after purchasing an additional 361,766 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Apollo Medical by 2.0% during the second quarter. Bank of New York Mellon Corp now owns 61,347 shares of the company’s stock worth $1,025,000 after purchasing an additional 1,205 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Apollo Medical by 52.4% during the second quarter. Charles Schwab Investment Management Inc. now owns 19,822 shares of the company’s stock worth $332,000 after purchasing an additional 6,816 shares in the last quarter. Institutional investors and hedge funds own 7.93% of the company’s stock.

Apollo Medical Company Profile

Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Featured Story: Cryptocurrencies

Get a free copy of the Zacks research report on Apollo Medical (AMEH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.